AI assistant
C-RAD Board/Management Information 2024
3148_rns_2024-03-25_1ed07777-c6f6-426a-9a80-a206daefec64.pdf
Board/Management Information
Open in viewerOpens in your device viewer
The CFO has resigned and will leave C-RAD
C-RAD's CFO Christoffer Herou, who took office on May 2, 2023, has today announced his resignation. Christoffer has a six-month notice period and will end his employment on September 25, 2024. A recruitment of a new CFO will start immediately.
For further information:
Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, [email protected]
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD. Inspiring excellence in cancer treatment.
C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com